Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

The Use of Eculizumab in HELLP Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04103489
Recruitment Status : Not yet recruiting
First Posted : September 25, 2019
Last Update Posted : October 11, 2019
Sponsor:
Information provided by (Responsible Party):
Johns Hopkins University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : January 4, 2023